ConductScience.org, home

Paper29615643

Computational repositioning and preclinical validation of mifepristone for human vestibular schwannoma.

Sagers JE and 10 others. Sci Rep, 2018. Cited by 18 papers, by iCite.

Cite this record

ConductScience Library. Computational repositioning and preclinical validation of mifepristone for human vestibular schwannoma. Papers, record 29615643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29615643

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Computational repositioning and preclinical validation of mifepristone for human vestibular schwannoma.
PubMed
Journal
Sci Rep
PubMed
Year
2018
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
0.85
iCite
Revised in PubMed
2026-11-02
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sagers JEJessica E
2Brown ASAdam Shttps://orcid.org/0000-0002-4393-1003
3Vasilijic SSasa
4Lewis RMRebecca M
5Sahin MIMehmet I
6Landegger LDLukas D
7Perlis RHRoy H
8Kohane ISIsaac S
9Welling DBD Bradley
10Patel CJChirag Jhttps://orcid.org/0000-0002-8756-8525
11Stankovic KMKonstantina M

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug Evaluation, PreclinicalMajor topic
Drug RepositioningMajor topic
MifepristoneMajor topic
Neuroma, AcousticMajor topic
Algorithms
Cell Line, Tumor
Gene Expression Regulation, Neoplastic
Humans

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R21 ES025052NIEHS NIH HHSUnited StatesR21ES025052PubMed and NIHNIH RePORTER
T32 DC000038NIDCD NIH HHSUnited StatesT32DC000038PubMed and NIHNIH RePORTER
R00ES023504NIHNIH RePORTER
R01DC015824NIHNIH RePORTER
T32HG002295NIHNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in30470790Publisher Correction: Computational repositioning and preclinical validation of mifepristone for human vestibular schwannoma.https://conductscience.org/library/papers/30470790

Source PubMed

Download CSV of comments and corrections

References61

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123049959Mechanisms of hearing loss in neurofibromatosis type 2.PLoS One2012https://conductscience.org/library/papers/23049959PubMed
27716084Growth inhibition of androgen-insensitive human prostate carcinoma cells by a 19-norsteroid derivative agent, mifepristone.Prostate1995https://conductscience.org/library/papers/7716084PubMed
325605792limma powers differential expression analyses for RNA-sequencing and microarray studies.Nucleic Acids Res2015https://conductscience.org/library/papers/25605792PubMed
424335938Natural history of vestibular schwannoma growth and hearing decline in newly diagnosed neurofibromatosis type 2 patients.Otol Neurotol2014https://conductscience.org/library/papers/24335938PubMed
524448296Aspirin intake correlates with halted growth of sporadic vestibular schwannoma in vivo.Otol Neurotol2014https://conductscience.org/library/papers/24448296PubMed
619146696Are animal models predictive for humans?Philos Ethics Humanit Med2009https://conductscience.org/library/papers/19146696PubMed
720332480Efficacy of the progesterone receptor antagonist mifepristone for palliative therapy of patients with a variety of advanced cancer types.Anticancer Res2010https://conductscience.org/library/papers/20332480PubMed
824778047Evidence that Mifepristone, a progesterone receptor antagonist, can cross the blood brain barrier and provide palliative benefits for glioblastoma multiforme grade IV.Anticancer Res2014https://conductscience.org/library/papers/24778047PubMed
926219339A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.Oncotarget2015https://conductscience.org/library/papers/26219339PubMed
1016002463Role of tyrosine kinase inhibitors in cancer therapy.J Pharmacol Exp Ther2005https://conductscience.org/library/papers/16002463PubMed
1125616959Nonsteroidal anti-inflammatory medications are cytostatic against human vestibular schwannomas.Transl Res2015https://conductscience.org/library/papers/25616959PubMed
1218670322Vestibular schwannoma quantitative polymerase chain reaction expression of estrogen and progesterone receptors.Laryngoscope2008https://conductscience.org/library/papers/18670322PubMed
1323555840Bevacizumab treatment for meningiomas in NF2: a retrospective analysis of 15 patients.PLoS One2013https://conductscience.org/library/papers/23555840PubMed
1420729918Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas.Oncogene2010https://conductscience.org/library/papers/20729918PubMed
1521849664Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease.Sci Transl Med2011https://conductscience.org/library/papers/21849664PubMed
1619414344
Levonorgestrel, medroxyprogesterone and progesterone cause a concentration-dependent reduction in endometrial cancer (Ishikawa) cell density, and high concentrations of progesterone and mifepristone act in synergy.
Anticancer Res2009https://conductscience.org/library/papers/19414344PubMed
1712925520Exploration, normalization, and summaries of high density oligonucleotide array probe level data.Biostatistics2003https://conductscience.org/library/papers/12925520PubMed
1814960456affy--analysis of Affymetrix GeneChip data at the probe level.Bioinformatics2004https://conductscience.org/library/papers/14960456PubMed
1919889208Expression of estrogen and progesterone receptors in vestibular schwannomas and their clinical significance.J Negat Results Biomed2009https://conductscience.org/library/papers/19889208PubMed
2020736812Erlotinib for progressive vestibular schwannoma in neurofibromatosis 2 patients.Otol Neurotol2010https://conductscience.org/library/papers/20736812PubMed

See all 61 referencesDownload CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
41756440N-Cadherin Dynamically Regulates Schwannoma Migration and Represents a Novel Therapeutic Target in NF2-Related Schwannomatosis.Res Sq2026https://conductscience.org/library/papers/41756440PubMed
41300330Immunohistopathology of Cochleovestibular Schwannoma in Human Temporal Bone Specimens.Biology (Basel)2025https://conductscience.org/library/papers/41300330PubMed
40171318Why Consider Aspirin for the Treatment of Vestibular Schwannoma? A Brief Review and Randomized, Double-Blind, Placebo-Controlled Study Proposal.Laryngoscope Investig Otolaryngol2025https://conductscience.org/library/papers/40171318PubMed
39792982Angiotensin-Receptor Blockers Prevent Vestibular Schwannoma-Associated Hearing Loss.Otol Neurotol2025https://conductscience.org/library/papers/39792982PubMed
37629179Drug Repositioning for Refractory Benign Tumors of the Central Nervous System.Int J Mol Sci2023https://conductscience.org/library/papers/37629179PubMed
35869506The effects of mifepristone on the structure of human decidua and chorion and Bax and Bcl-2 expression at early stage of pregnancy.BMC Pharmacol Toxicol2022https://conductscience.org/library/papers/35869506PubMed
35628268A Critical Overview of Targeted Therapies for Vestibular Schwannoma.Int J Mol Sci2022https://conductscience.org/library/papers/35628268PubMed
33604573New developments in neurofibromatosis type 2 and vestibular schwannoma.Neurooncol Adv2021https://conductscience.org/library/papers/33604573PubMed
33017025Computational Drug Repositioning Identifies Potentially Active Therapies for Chordoma.Neurosurgery2021https://conductscience.org/library/papers/33017025PubMed
33013614Progression of Contralateral Hearing Loss in Patients With Sporadic Vestibular Schwannoma.Front Neurol2020https://conductscience.org/library/papers/33013614PubMed
32095298Treatment of a Woman with Inoperable Meningioma Using Mifepristone for 26 Years.Case Rep Neurol Med2020https://conductscience.org/library/papers/32095298PubMed

Download CSV of cited by

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29615643

GET https://conductscience.org/api/papers/v1/29615643/references?page=2